Last reviewed · How we verify

NCT03647618

Anatomy Guidance for Regional Anaesthesia

Completed Last updated 25 September 2020
What this trial tests

trial testing Ultrasound in Ultrasound Imaging in 151 participants. Completed in 31 March 2020.

Timeline
20 December 2018
Primary endpoint
31 March 2020
31 March 2020

Quick facts

Lead sponsorMedaphor Limited
StatusCompleted
Study typeOBSERVATIONAL
Enrollment151
Start date20 December 2018
Primary completion31 March 2020
Estimated completion31 March 2020
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Medaphor Limited

Who can join

18 and older, any sex, with Ultrasound Imaging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This mutlicentre study at three hospitals in south Wales, UK, will be used to determine if modern machine learning techniques can help the anaesthetist locate the target by highlighting key anatomical features on the ultrasound image in real time. The study consists of two phases: The objective of Phase I is to train a computer-aided system to identify target structures in regional anaesthesia when applied in the following categories: * Adductor canal * Popliteal * Fascia Iliaca * Rectus sheath * Axillary The objective of Phase II is to estimate the success rate and safety of the computer system being developed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Ultrasound

Trials testing the same drug.

Other recruiting trials for Ultrasound Imaging

Currently open trials in the same condition.

Other Medaphor Limited trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03647618.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing